This section, illustrated by Figure 1 for mRNA levels and Figure 2 for protein levels, aimed to comprehensively evaluate the regulation of ADAM10 expression in both acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) cases, specifically examining the impact of chemotherapeutic treatments (vincristine, methotrexate, and doxorubicin) on ALL samples. Here, ADAM10 is linked to acute lymphoblastic leukemia.